Global Non-Hodgkin Lymphoma Therapeutic Market Analysis

$3,000.00$7,500.00

  • Type: Oncology area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 178

  • Format: PPT, PDF

Global Non-Hodgkin Lymphoma Therapeutics Market Segmented by Type of Therapy (Chemotherapy, Radiation Therapy, Targeted Therapy, and Other Types of Therapies), by Cell Type (B-cell Lymphoma and T-cell Lymphoma), and by Geography (North America, Europe, Latin America and Middle East and Africa) – Growth, Trends and Forecast, 2019-2028

 

Clear

Report Overview

The global Non-Hodgkin Lymphoma therapeutics market size stood at around USD XX billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 7.4% during the forecast period.

Lymphoma is one of the most hazardous and life threatening type of cancer, related to lymphocytes, an important type of white blood cells. Non-Hodgkin’s lymphomas (NHL) is a distinct group of blood cancer, which includes large variety of lymphomas, excluding Hodgkin’s lymphomas. Non-Hodgkin’s lymphoma (NHL) varies in their severity, from mild to fatal.

Market Drivers and Restraints

Certain factors that are driving the market growth include a rise in the prevalence of NHL, demand for innovative drugs and novel technologies, and an increase in the number of FDA approvals for NHL therapy drugs. In addition, an increase in public awareness about NHL, robust drug pipeline for the treatment of the disease, improved diagnostic techniques to detect NHL, and an increase in the prevalence of non-Hodgkin lymphoma are the factors fueling the NHL therapeutics market across the world. However, the high cost of NHL drugs and various complications associated with them are acting as major restraints for the non-Hodgkin lymphoma therapeutics market.

Additionally, stringent regulatory guidelines are limiting the growth of the market.

1. Global Non-Hodgkin Lymphoma Therapeutics Market Overview…………..
A. Market Size
2. Market Growth Drivers and Restraints…………………………………..…………
A. Market Drivers
I. Growing Burden of Non-Hodgkin Lymphoma (NHL)
II. Demand for Innovative Drugs and Novel Technologies
B. Market Restraints
I. High Cost of the Drugs Used in NHL Therapy
II. Side Effects Associated with NHL Drugs
3. Non-Hodgkin Lymphoma Epidemiology………………………..…………….……
A. Epidemiology by Geography
4. Non-Hodgkin Lymphoma Therapeutics Market Segmentation………………
A. By Type of Therapy
I. Chemotherapy
II. Radiation Therapy
III. Targeted Therapy
IV. Other
B. By Cell Type
I. B-cell Lymphoma
II. T-cell Lymphoma
C. By Region
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. South America Market Analysis
V. Middle East and Africa Market Analysis
5. Non-Hodgkin Lymphoma Major Market Share………………………………….…..
A. Market Analysis, Insights and Forecast
6. Competitive Landscape………………………………………………………….………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. AstraZeneca PLC Company overview, Product & Services, Strategies & Financials
B. Bayer AG Company overview, Product & Services, Strategies & Financials
C. F. Hoffmann La-Roche Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape….………………………………
A. Policy Changes and Reimbursement Scenario
9. Factors Driving Market Growth………………………………………………………
A. Key Industry Developments
B. Future Opportunities
10. Conclusion

Market Segmentation

By Types of Therapy:

On the basis of types of therapy, the market of Non-Hodgkin Lymphoma therapeutics market is segmented into chemotherapy, radiation therapy, targeted therapy and other types of therapies.

The radiation therapy segment is expected to hold a significant market share over the forecast period. Radiotherapy is the use of high-energy beams or particles to kill cancer cells, and it can be delivered from a source outside the body, i.e., external beam radiation or internally, such as brachytherapy. Usually, radiation treatments are given five days per week for several weeks. Radiation therapy is most effective when this kind of lymphoma is only found in one part of the body. According to the American Cancer Society, non-Hodgkin lymphoma (NHL) is one of the most common cancers in the United States that accounts for about 4% of all cancers. For non-Hodgkin disease, radiation therapy is used in the early stages. In the case of advanced lymphomas, radiation therapy is used along with chemotherapy for better treatment of NHL. If the lymphoma is widespread, palliative radiotherapy is very helpful. Radiotherapy is often very good at destroying non-Hodgkin disease cells. It mainly helps in relieving the symptoms caused by the lymphomas.

By Region:

By geography, the Non-Hodgkin Lymphoma therapeutics market is being segmented into North America, Europe, Asia Pacific, South America and Middle East and Africa.

Asia-Pacific is expected to show the highest growth rate over the forecast period. North America dominates the non-Hodgkin lymphoma therapeutics market, due to increasing technological advancements and the rising incidences of NHL in the country. However, Asia-Pacific is expected to propel the non-Hodgkin lymphoma therapeutics market, owing to factors, such as increasing accessibility to healthcare facilities in the region and increasing prevalence of NHL. With the growing awareness of the disease, increasing government initiatives, and an increase in the burden of disease, the market is expected to grow over the forecast period.

The image below depicts the Non-Hodgkin Lymphoma therapeutics market as growth rate by region.

Top Major Players

The non-Hodgkin lymphoma therapeutics market is highly competitive and consists of a few major players. Companies, like AstraZeneca, Baxter International Inc., Bayer AG, Bristol Myers Squibb Company, Teva Pharmaceutical Industries Ltd, Eli Lilly and Co., F. Hoffmann La-Roche Ltd, GlaxoSmithKline PLC, hold substantial market shares in the non-Hodgkin lymphoma therapeutics market.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements